Immunomodulator for asthma treatment (L-11894) .: NR16-175/2017E-PDF
“To address the need for a safe, disease-modifying treatment, the NRC has developed an immunomodulator that suppresses the unbalanced immune response that causes asthma”--Highlights.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847586&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | Immunomodulator for asthma treatment (L-11894) . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Immunomodulateur pour le traitement de l’asthme (L-11894). Caption title. "December 2017." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, [2018] |
| Description | [1] p. : col. ill. |
| ISBN | 9780660239637 |
| Catalogue number |
|
| Subject terms | Immunological adjuvants Asthma |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: